Subjective Measures, Objective Outcomes: Data Quality in Atopic Dermatitis Clinical Trials
VirTrial
JULY 7, 2024
In recent years, there has been significant activity in the AD clinical trial landscape, including the approval of novel systemic therapies. Accurate measurement of AD severity over time is crucial for evaluating treatment efficacy in these trials. In these ways, the two assessments measure BSA quite differently.
Let's personalize your content